Johns Hopkins HIV Guide
Testosterone
INDICATIONS
FDA
FDA
- Hypogonadism (replacement therapy recommended for men with low or low-normal levels)
- Wasting
- Hypogonadotropic hypogonadism (congenital or acquired)
- Palliation of inoperable mammary cancer in women
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 4, 2016
Citation
Smith, Janessa, and Paul A Pham. "Testosterone." Johns Hopkins HIV Guide, 2016. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545200/all/Testosterone.
Smith J, Pham PA. Testosterone. Johns Hopkins HIV Guide. 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545200/all/Testosterone. Accessed June 1, 2023.
Smith, J., & Pham, P. A. (2016). Testosterone. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545200/all/Testosterone
Smith J, Pham PA. Testosterone [Internet]. In: Johns Hopkins HIV Guide. ; 2016. [cited 2023 June 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545200/all/Testosterone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Testosterone
ID - 545200
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2016/12/04/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545200/all/Testosterone
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
